| Literature DB >> 25477908 |
Tatiana Castro Abreu Pinto1, Natália Silva Costa1, Ana Beatriz de Almeida Corrêa1, Ivi Cristina Menezes de Oliveira1, Marcos Correa de Mattos1, Alexandre Soares Rosado1, Leslie Claude Benchetrit1.
Abstract
Streptococcus agalactiae (GBS) is a major source of human perinatal diseases and bovine mastitis. Erythromycin (Ery) and tetracycline (Tet) are usually employed for preventing human and bovine infections although resistance to such agents has become common among GBS strains. Ery and Tet resistance genes are usually carried by conjugative transposons (CTns) belonging to the Tn916 family, but their presence and transferability among GBS strains have not been totally explored. Here we evaluated the presence of Tet resistance genes (tetM and tetO) and CTns among Ery-resistant (Ery-R) and Ery-susceptible (Ery-S) GBS strains isolated from human and bovine sources; and analyzed the ability for transferring resistance determinants between strains from both origins. Tet resistance and int-Tn genes were more common among Ery-R when compared to Ery-S isolates. Conjugative transfer of all resistance genes detected among the GBS strains included in this study (ermA, ermB, mef, tetM and tetO), in frequencies between 1.10(-7) and 9.10(-7), was possible from bovine donor strains to human recipient strain, but not the other way around. This is, to our knowledge, the first report of in vitro conjugation of Ery and Tet resistance genes among GBS strains recovered from different hosts.Entities:
Keywords: Streptococcus agalactiae (GBS); conjugative transposons; erythromycin resistance; tetracycline resistance
Mesh:
Substances:
Year: 2014 PMID: 25477908 PMCID: PMC4204959 DOI: 10.1590/s1517-83822014000300004
Source DB: PubMed Journal: Braz J Microbiol ISSN: 1517-8382 Impact factor: 2.476
Characteristics of the nine Streptococcus agalactiae strains included in the filter mating conjugation experiments performed in this study.
| Strain | Clinical origin | Erythromycin genotype | Tetracycline genotype | Frequency | Added to the medium | |
|---|---|---|---|---|---|---|
| Donor strains | ||||||
| 87169 | Bovine | None | + | 1.10−7 | None | |
| 90003 | Human | + | 9.10−7 | Erythromycin | ||
| 96008 | Human | + | 9.10−7 | Tetracycline | ||
| 96009 | Human | − | ND | NA | ||
| 02031 | Human | − | ND | NA | ||
| 06003 | Bovine | − | ND | NA | ||
| 06005 | Bovine | + | 1.10−7 | Erythromycin/tetracycline | ||
| Recipient strains | ||||||
| 88596 | Human | None | None | − | NA | NA |
| B66 | Bovine | None | None | − | NA | NA |
Frequency of conjugation expressed as the number of transconjugants per cfu of recipient; ND, not determined since transconjugants were not detected; NA, not applicable.
Antimicrobials added to the conjugation medium in some replicas: erythromycin at 0.5 μg/mL and tetracycline at 4 μg/mL; NA, not applicable.